Product Information
Name:
Palivizumab
Synonyms:
- Synagis, MEDI 493
CAS:
Description:
Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
